IV FCM reduced the composite primary endpoint of first HF hospitalisation or cardiovascular death, with a p value just short of significance (0.059), but did improve total HF hospitalisations up to 52 weeks post treatment.
1
—
—
IV FCM reduced the composite primary endpoint of first HF hospitalisation or cardiovascular death, with a p value just short of significance (0.059), but did improve total HF hospitalisations up to 52 weeks post treatment.